# Natural Killer (NK) Cell Transplantation for AML

> **NCT00187096** · NA · COMPLETED · sponsor: **St. Jude Children's Research Hospital** · enrollment: 49 (actual)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

- **DRUG:** Cyclophosphamide, Fludarabine, Clofarabine, Etoposide, Interleukin-2
- **PROCEDURE:** Natural Killer Cell Infusion
- **DEVICE:** CliniMACS System

## Key facts

- **NCT ID:** NCT00187096
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2012-02
- **Final completion:** 2013-03
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2014-06-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00187096

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00187096, "Natural Killer (NK) Cell Transplantation for AML". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00187096. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*